Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
marta wacewicz
(2 results)?
Activity of cabozantinib in further line treatment of metastatic clear cell renal cell carcinoma. Real-world experience in a single-center retrospective study.
Contemp Oncol (Pozn). 2023;27(3):190-197. doi: 10.5114/wo.2023.133545. Epub 2023 Dec 7.
Contemp Oncol (Pozn). 2023.
PMID: 38239858
Free PMC article.
Prognostic value of pan-immune-inflammation value and body mass index in geriatric patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first line treatment. A single-center retrospective study.
Domański P, Jarosińska J, Kruczyk B, Piętak M, Mydlak A, Demkow T, Kuncman Ł, Darewicz M, Sikora-Kupis B, Michalski W, Kucharz J.
Domański P, et al. Among authors: darewicz m.
Contemp Oncol (Pozn). 2023;27(4):242-248. doi: 10.5114/wo.2023.134786. Epub 2024 Jan 30.
Contemp Oncol (Pozn). 2023.
PMID: 38405212
Free PMC article.
Item in Clipboard
Adverse Events of Cabozantinib as a Potential Prognostic Factor in Metastatic Renal Cell Carcinoma Patients: Real-World Experience in a Single-Center Retrospective Study.
Domański P, Piętak M, Kruczyk B, Jarosińska J, Mydlak A, Demkow T, Darewicz M, Sikora-Kupis B, Dumnicka P, Kamzol W, Kucharz J.
Domański P, et al. Among authors: darewicz m.
Biomedicines. 2024 Feb 9;12(2):413. doi: 10.3390/biomedicines12020413.
Biomedicines. 2024.
PMID: 38398014
Free PMC article.
Item in Clipboard
Cite
Cite